Philadelphia, PA USA
Add to Favorites | Newsroom RSS | Share

Our News on Newswise

The Wistar Institute Appoints Farokh Dotiwala, M.B.B.S., Ph.D., as Assistant Professor in the Vaccine Center


Antibiotic-resistant strains of bacteria like Mycobacterium tuberculosis and Staphylococcus and pathogens like malaria are emerging throughout the world. Dotiwala’s research centers on the mechanisms of killer immune cells—such as natural killer...
27-Mar-2017 9:05 AM EDT Add to Favorites

The Wistar Institute Appoints Mohamed Abdel-Mohsen, Ph.D., as Assistant Professor in the Vaccine Center

The Wistar Institute announces the appointment of Mohamed Abdel-Mohsen, Ph.D., as assistant professor in Wistar’s Vaccine Center.
15-Mar-2017 11:05 AM EDT Add to Favorites

Wistar Research Teams Awarded More Than $4.7 Million in Funding


Wistar scientists have secured more than $4,720,000 million in research funds.
13-Mar-2017 9:05 AM EDT Add to Favorites

Philadelphia Research Consortium Launched to Speed Access to Preclinical Research Capabilities Across Philadelphia’s Life Sciences Community

The Wistar Institute, together with many regional academic institutions driving life sciences discoveries, has launched the Philadelphia Research Consortium – a preclinical research network for facilitating easy access to our region’s robust...
1-Mar-2017 10:30 AM EST Add to Favorites

Genetic Variant of the p53 Gene Linked to Breast Cancer Risk in Premenopausal African American Women

Scientists at The Wistar Institute in collaboration with Roswell Park Cancer Institute found a significant association between a rare genetic variant of the p53 gene present in African American women and their risk of developing breast cancer in...
27-Feb-2017 8:05 AM EST Add to Favorites

A Novel DNA Vaccine Design Improves Chances of Inducing Anti-Tumor Immunity


Scientists at The Wistar Institute and Inovio Pharmaceuticals, Inc. have devised a novel DNA vaccine approach through molecular design to improve the immune responses elicited against one of the most important cancer antigen targets.
24-Feb-2017 11:05 AM EST Add to Favorites

Anti-Aging Gene Identified as a Novel Promising Therapeutic Target for Older Melanoma Patients

Wistar scientists have shown an anti-diabetic drug can inhibit the growth of melanoma in older patients by activating an anti-aging gene that in turn inhibits a protein involved in metastatic progression and resistance to targeted therapies for the...
22-Feb-2017 1:00 PM EST Add to Favorites

Penn and Wistar Researchers Find “Sweet Spot” Where Tissue Stiffness Promotes Cancer’s Spread


University of Pennsylvania and Wistar scientists have studied the physical feedback mechanisms between cancer cells and their environment and described how this interplay allows the migration and invasion of tumor cells.
21-Feb-2017 12:05 PM EST Add to Favorites

Our YouTube Videos

Chat now!